Giant Biogene Holding Co (HKSE:02367) EBIT per Share : HK$1.95 (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Giant Biogene Holding Co EBIT per Share?

Giant Biogene Holding Co's EBIT per Share for the six months ended in Dec. 2023 was HK$1.11. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.95.

During the past 12 months, the average EBIT per Share Growth Rate of Giant Biogene Holding Co was 43.80% per year. During the past 3 years, the average EBIT per Share Growth Rate was 24.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Giant Biogene Holding Co's EBIT per Share or its related term are showing as below:

HKSE:02367' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 19.3 Med: 21.7 Max: 24.1
Current: 24.1

During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Giant Biogene Holding Co was 24.10% per year. The lowest was 19.30% per year. And the median was 21.70% per year.

HKSE:02367's 3-Year EBIT Growth Rate is ranked better than
72.61% of 1497 companies
in the Consumer Packaged Goods industry
Industry Median: 6.5 vs HKSE:02367: 24.10

Giant Biogene Holding Co's EBIT for the six months ended in Dec. 2023 was HK$1,060 Mil.

Giant Biogene Holding Co EBIT per Share Historical Data

The historical data trend for Giant Biogene Holding Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Giant Biogene Holding Co EBIT per Share Chart

Giant Biogene Holding Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

0.76

0.97

1.20

1.29

1.94

Giant Biogene Holding Co Semi-Annual Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT per Share	Get a 7-Day Free Trial			-	0.61	0.75	0.84	1.11

Giant Biogene Holding Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Giant Biogene Holding Co's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	1908.864	/	982.717
=	1.94

Giant Biogene Holding Co's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	1060.485	/	959.742
=	1.10

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$1.95

Giant Biogene Holding Co (HKSE:02367) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Giant Biogene Holding Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Giant Biogene Holding Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Giant Biogene Holding Co (HKSE:02367) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Giant Biogene Holding Co Ltd (HKSE:02367) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1855, Shanglin Yuan 7th Road, Chang’an District, Shaanxi Province, Xi’an, CHN

Website

http://www.xajuzi.com

Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.

Giant Biogene Holding Co (HKSE:02367) Headlines

No Headlines